1. Selective effects oflipiodolised antitumor agents;Kanematsu, T.; Inokuchi, K.; Sugimachi, K.; Furuta, T.; Sonoda, T.; Tamura, S.;JSurgOncol,1984
2. A 5-year experience of lipiodolisation: selective regional chemotherapy;Kanematsu, T.; Furuta, T.; Takenaka, K.; Matsumata, T.; Yoshida, Y.; Nishizaki, T.;Hepatology; with hepatocellular carcinoma,1989
3. Irresectable hepatoma treated by intrahepatic iodized oil doxorubicin hydrochloride: Initial results;Kirk, S.; Blumgart, R.; Craig, B.; Rosen, A.; Terblanche, J.; Spence, R.A.J.;Surgery,1991
4. Diagnosis and non-surgical treatment of hepatocellular carcinoma;Okuda, K.;Hepatogastroenterology,1990
5. The determination of sample sizes for use with the exact conditional test in 2 x 2 comparative trials;Gail, M.; Gart, J.J.;Biometrics,1973